Log In
BCIQ
Print this Print this
 

WT1 vaccine, galinpepimut-S

  Manage Alerts
Collapse Summary General Information
Company Memorial Sloan Kettering Cancer Center
DescriptionVaccine comprised of Wilms tumor 1 (WT1) peptides administered in combination with an adjuvant and immune modulator
Molecular Target Wilms tumor 1 (WT1)
Mechanism of Action 
Therapeutic ModalityPreventive vaccine

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/04/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today